Electrostatic field potential effects on metastatic cancer treatment

Improving the drug delivery process during chemotherapy under electrostatic field for metastatic cancer patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190904044697N9

Enrollment

Registered

2024-11-04

Start date

2024-10-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced and Metastatic cancers. Malignant carcinoid tumors of other sites

Interventions

Intervention 1: "Intervention group: in this group, patients are treated with electrostatic patch while injecting conventional chemotherapy drugs in each course". Intervention 2: "Control group: in th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with solid tumors who are candidates for chemotherapy

Exclusion criteria

Exclusion criteria: Male gender Pregnant women Patients with benign tumors Impaired Complete Blood Cell Count (CBC) or serum electrolytes Sepsis Cardiac Arrhythmia Alcohol abuser Substance abuser

Design outcomes

Primary

Measure	Time frame
Tumor size. Timepoint: Investigating the effect of electrostatic fields in increasing the effects of chemotherapy in the treatment of cancer patients in the middle of treatment and the end of treatment. Method of measurement: Para clinic imaging.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Abdolahad

Tehran University College of Engineering

m.abdolahad@ut.ac.ir+98 21 8802 7756

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026